¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"visual area, second"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual-spatial agnosia
    ½Ã°ø°£ÀνĺҴÉ(Áõ), ½Ã°ø°£½ÇÀÎÁõ
  • apical area
    Ä¡±Ù÷´ÜºÎ
  • arcuate area
    Ȱ²Ã±¸¿ª
  • area
    1. ±¸¿ª, ¿µ¿ª, ¿ª 2. ºÎÀ§, ºÎ 3. ¸éÀû
  • area cerebrovasculosa
    ³úÇ÷°ü´õ¹Ì
  • area cribrosa
    ü±¸¿ª
  • area monitoring
    ±¸¿ª°¨½Ã
  • area paraterminalis
    Á¾¸»ÆÇ¿·±¸¿ª
  • area pellucida
    Åõ¸í±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • area sampling
    Áö¿ªÃßÃâ(¹ý)
  • association area
    ¿¬ÇÕ±¸¿ª
  • auditory projection area
    û°¢Åõ»ç±¸¿ª
  • auditory sensation area
    °¡Ã»¹üÀ§, û°¢±¸¿ª
  • auditosensory area
    °¡Ã»¹üÀ§, û°¢±¸¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • area
    ±¸¿ª, ¿µ¿ª, ¿ª, ºÎ, ¸éÀû
  • area cerebrovasculosa
    ³úÇ÷°ü±¸¿ª
  • area cribrosa
    ü±¸¿ª
  • area paraterminalis
    Á¾¸»ÆÇ¿·±¸¿ª
  • area pellucida
    Åõ¸í±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • absorbing area
    Èí¼ö±¸¿ª
  • acoustic area
    û°¢±¸¿ª, û¿ª
  • apical area
    Ä¡±Ù÷´ÜºÎ
  • arcuate area
    Ȱ²Ã±¸¿ª
  • area monitoring
    ±¸¿ª°¨½Ã
  • area sampling
    Áö¿ªÃßÃâ¹ý
  • association area
    ¿¬ÇÕ±¸¿ª
  • auditory projection area
    û°¢Åõ»ç±¸¿ª
  • auditory sensation area
    °¡Ã»¹üÀ§, û°¢±¸¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • posr rolandic area =postcentral a.
    ÈķѶõµå
  • posr rolandic area =postcentral a.
    ÈķѶõµå±¸·É(ý­¡­ÏµçÐ), ÈÄÁ߽ɱ¸·É(ý­ñéãý ϵçÐ).
  • posterior hypothalamic area
    ÈĽûóÇϺΠ¿µ¿ª.
  • posterior intercondylar area
    µÚÀ¶±â»çÀ̱¸¿ª
  • premamillary area
    ÀüÀ¯µÎü¿µ¿ª.
  • premotor area
    Àü¿îµ¿¿µ¿ª(îñê¡ÔÑçÐæ´).
  • preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
  • pretectal area
    µ¤°³¾Õ±¸¿ª
  • primary sensory area
    ÀÏÂ÷°¨°¢¿µ¿ª (¡­çÐæ´).
  • pulmonary area
    Æó¿µ¿ª, Æó¾ß(øËå¯).
  • pupil area
    µ¿°øºÎÀ§
  • pupillary area =p. zone
    µ¿°ø¾ß(ÔÚÍîå¯).
  • pyramidal area
    Ãßü¾ß, ÇǶó¹Ô¿µ¿ª.
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • second-generation machines
    Á¦ 2 ¼¼´ë ±â±â (ð¯ ì£ á¦ÓÛ ÐïѦ)
  • second-line chemotherapy
    2Â÷(¼±ÅÃ)Ç×¾ÏÈ­Çпä¹ý
  • second-look laparotomy
    2Â÷Ã߽𳺹¼ú
  • second-look operation
    2Â÷Ã߽üö¼ú
  • second-messenger system
    ÀÌÂ÷Àü´Þ°è
  • union by second intention
    Á¦2À¯ÇÕ.
  • upper second molar
    »ó¾ÇÁ¦À̴뱸ġ(ß¾äÉð¯ì£ÓÞÏ¿öÍ).
  • upper second premolar
    »ó¾ÇÁ¦À̼ұ¸Ä¡(ß¾äÉð¯ì£á³Ï¿öÍ).
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • aphasia, visual
    ½Ã°¢¼º ½Ç¾îÁõ
  • binocular visual acuity
    ¾ç¾È½Ã·Â
  • central visual acuity
    Á߽ɽ÷Â
  • complex visual discrimination
    º¹Çսð¢ºÐº°(ÜÜùêãÊÊÆÝÂܬ)
  • depression of visual field
    ½Ã¾ß°¨µµÀúÇÏ, ½Ã¾ßħÇÏ
  • developmental test of visual motor integration
    ½Ã°¢¿îµ¿ÅëÇÕ(ãÊÊÆê¡ÔÑ÷Öùê)¹ß´Þ°Ë»ç(Û¡Ó¹ËþÞÛ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
VFD Visual Field Defect
VI Visual Identity
BIVAS body image visual analogue scale
BVE binocular visual efficiency; blood vessel endothelium; blood volume expander
BVMGT Bender Visual-Motor Gestalt Test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
T2 the Second
BVRT Benton Visual Retention Test
BCVA Best corrected visual acuity
BSCVA Best spectacle corrected visual acuity
CVI Cortical visual impairment
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Brodmann's area
    ºê·Îµå¸¸ ¿µ¿ª
    ´ë³ú ÇÇÁúÀÇ ¿©·¯ ºÐ¾ß·Î¼­ ±× ¼¼Æ÷ÃþÀÇ ¹è¿­¿¡ ÀÇÇÏ¿© ±¸º°µÇ°í ½Äº°µÈ´Ù.
  • central chemosensitive area
    ÁßÃß È­ÇÐ °¨¼ö ¿µ¿ª
  • cingulate area
    ´ë»ó¸é
    ´ë»óȸ¿Í ´ë»óȸÇùÀ¸·Î µÇ´Â ¸é.
  • clearing area
    Åõ¸í ºÎÀ§
  • contact area
    Á¢Ã˺Î
  • cortical area
    ÇÇÁú ¿µ¿ª, ÇÇÁú ºÎÀ§
  • denervated area
    Å»½Å°æ ¿µ¿ª, ºÎÀ§
  • denture bearing area
    ÀÇÄ¡ ºÎ´ã ºÎÀ§
    ÀÇÄ¡¸¦ ÀåÂøÇÏ¿´À» ¶§ ÀÇÄ¡ÀÇ Á¶Á÷ ¸é°ú Á¢ÃËÇÏ´Â Á¶Á÷ ¸éÀ¸·Î, Á÷Á¢ ±³ÇÕ·ÂÀ» ¹Þ´Â ºÎÀ§ÀÌ´Ù.
  • denture foundation area
    ÀÇÄ¡ ±âÀú¸é
    ÀÇÄ¡ÀÇ ÁöÁö¿¡ ±â¿©ÇÏ´Â ±¸°­³» Á¶Á÷ÀÌ´Ù.
  • distraction technique for the cervicospinal area
    °æÃߺΠ½ÅÀü¼ú
  • donor area
    °ø¿©ºÎ
  • endemoenzootic area
    Àμöº´ À¯ÇàÁö
  • epigasric area
    À§ »óºÎ
  • epiphyseal area
    °ñ´ÜºÎ
    µ¿ÀǾî=e
  • erythematous area
    È«¹Ý ºÎÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
second heart sound The second sound heard on auscultation of the heart; signifies the beginning of diastole and is due to closure of the semilunar valves.
Synonym: second sound.
(05 Mar 2000)
second incisor Second maxillary or mandibular permanent or deciduous tooth on either side of the midsagittal plane of the head.
Synonym: lateral incisor.
(05 Mar 2000)
second law of thermodynamics <physics> All of the chemical and physical processes in a closed system tend to drive that system toward maximum entropy.
Clausius statement: No device can operate in a cycle and allow heat to transfer from a colder body to a hotter body unless other compensating activities are taking place.
Kelvin-Planck statement: no device can operate in a constant-temperature cycle and convert the heat it receives into work, unless other other compensating activities are taking place.
(09 Oct 1997)
second line chemotherapy <oncology> Chemotherapy given for a tumour which has already failed to respond to a first chemotherapy regimen (called first line).
(16 Dec 1997)
second-look operation Exploratory celiotomy within a year after apparently curative resection of intra-abdominal cancer, in patients with no sign or symptom of recurrence, to resect an occult tumour if present.
(05 Mar 2000)
second meiotic division The second of two consecutive divisions of the nucleus of an eukaryotic cell during the process of meiosis. It includes the following stages of meiosis: prophase II, metaphase II, anaphase II, and telophase II.
(09 Oct 1997)
second messenger <molecular biology> In many hormone sensitive systems the systemic hormone does not enter the target cell but binds to a receptor and indirectly affects the production of another molecule within the cell, this diffuses intracellularly to the target enzymes or intracellular receptor to produce the response. This intracellular mediator is called the second messenger.
Examples include cyclic AMP, cyclic GMP, IP3 and diacylglycerol.
(18 Nov 1997)
second messenger systems Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.
(12 Dec 1998)
second molar Seventh permanent or fifth deciduous tooth in the maxilla and mandible on either side of the midsagittal plane of the head following the arch form.
(05 Mar 2000)
second-order conditioning The use of a previously successfully conditioned stimulus as the unconditioned stimulus for further conditioning.
(05 Mar 2000)
second-order kinetics A term describing the reaction rate of a chemical reaction in which the rate is proportional to the product of the concentrations (in moles) of two of the reactants (also called bimolecular kinetics), or to the square of the molar concentration of the reactant if there is only one. Such a reaction might have an equation like rate = k[A][B] or rate = k[A]2, where k is the reaction rate constant, [A] is the concentration of reactant A, and [B] is the concentration of reactant B.
(09 Oct 1997)
second parallel pelvic plane The plane extending from the middle of the posterior surface of the pubic symphysis to the junction of the second and third sacral vertebrae, and laterally passing through the ischial bones over the middle of the acetabulum.
Synonym: second parallel pelvic plane, wide plane.
(05 Mar 2000)
second set rejection An accelerated rejection of a transplant that occurs when an individual has been previously sensitised to the graft.
(05 Mar 2000)
second sight 1. <ophthalmology> Improved near vision in the aged as a result of increased refractivity of the nucleus of the lens causing myopia.
Synonym: senile lenticular myopia.
2. The power of discerning what is not visible to the physical eye, or of foreseeing future events. Such as are of a disastrous kind, the capacity of a seer or prophetic vision.
Source: Websters Dictionary
(01 Mar 1998)
second signaling system <psychology> Pavlovian term for speech in which words are considered to be the second signals capable of producing conditioned responses.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • second rate
    2·ùÀÇ;¿­µîÇÑ;Æò¹üÇÑ
  • second rater
    2·ùÀÇ »ç¶÷(°Í);Æò¹üÇÑ »ç¶÷ (°Í);ÇÏÀÝÀº »ç¶÷(°Í)
  • second sight
    õ¸®¾È;¼±°ßÁö¸í
  • second sighted
    ¼±°ßÁö¸íÀÌ ÀÖ´Â
  • second sourcing
    2Â÷ °ø±ÞÀÚÀÇ
  • second story
    (¹Ì)2ÃþÀÇ
  • second strike
    ÃÖÃÊ ¹Ý°Ý¿ëÀÇ(ÇÙ¹«±â°¡ ¼û°ÜÁ® À־ ÇÙ°ø°ÝÀÇ º¸º¹¿ëÀÌ µÇ´Â)
  • second thoughts
    Àç°í
  • second wind
    (°Ý½ÉÇÑ ¿îµ¿ µÚÀÇ)µÇµ¹¸° ¼û;¿ø±âÀÇ È¸º¹
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á